Kidney Failure Chronic
📧 Sign up to get email alerts when something new happens for Kidney Failure Chronic.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-12-09Clinical Trial Update: Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease [Phase 4]
A Phase 4 trial investigating left ventricular hypertrophy and spironolactone in chronic kidney disease has been withdrawn.
-
EMA withdrawal · 2009-01-28EMA Withdrawn: Nespo (darbepoetin alfa) — Dompé Biotec S.p.A.
EMA has withdrawn Nespo (darbepoetin alfa) from Dompé Biotec S.p.A.'s portfolio.